OR WAIT null SECS
September 16, 2021
Life sciences companies have an opportunity to craft a sales approach that resonates with clients, protects against future disruptions and stands out from the competition.
September 10, 2021
White House officials recently announced a nearly $3 billion program to ramp up production of vaccines and their components to better serve patients in the U.S. and globally.
August 30, 2021
Using the interview process to ensure high organizational standards.
August 26, 2021
Sy Chyi Yeoh looks at some of the practical considerations faced by Chinese firms looking to expand overseas.
August 13, 2021
Rory Mullen outlines Ireland’s importance to multinational pharma in the changing EU landscape.
August 12, 2021
All eyes are watching closely to see how well Viatris and Biocon Biologics’ Semglee, approved by FDA on July 28, competes with Sanofi’s well-established, long-acting insulin analog, Lantus.
August 10, 2021
Changes necessitated by COVID will drive unprecedented transformation of industry.
COVID-19 may be the latest challenge to primary care physicians, but it’s just one of many threatening the profession, including the increased focus on specialty drug markets—if PCPs are left out of the equation.
Looking Back at 2003–2006.
July 13, 2021
GSK‘s President of US Pharmaceuticals, Maya Martinez-Davis, outlines her organization’s evolving diversity and inclusion commitments.
